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Several studies have provided evidence that the cellular cytoskeleton may be involved in the assembly and budding of
retroviruses. In fractionation studies of HIV-1-infected CEM cells, the majority of the unprocessed Gag polyprotein cofrac-
tionated with the cellular cytoskeleton. In vivo and in vitro analyses of this interaction indicated that the unprocessed Gag
polyprotein is capable of association with polymerized actin (F-actin). Binding of Gag to F-actin may be involved in the
assembly or budding of HIV-1. q 1996 Academic Press, Inc.
The cytoskeleton is a cytoplasmic network composed (ICN Biomedicals, Inc., Irvine, CA) (1.0 mCi/ml). The cells
of three types of protein filaments: microtubules, microfil- were washed after the pulse with cytoskeletal stabiliza-
aments, and intermediate filaments (1). The shape and tion buffer (CSB) [100 mM PIPES adjusted to pH 6.9 with
internal arrangement of all eukaryotic cells reflect the KOH, 1 mM EGTA, 3% PEG 6000, 66 mg phalloidin/ml
organization of the cytoskeleton, a structure experimen- (Molecular Probes, Inc., Eugene, OR)] and then incubated
tally defined as the cellular fraction remaining after cell 7 min at 377 in CSB plus 2 mM GTP, 1% Triton X-100, 2
treatment with non-ionic detergents (1–3). Several obser- mg/ml aprotinin, 50 mg/ml PMSF, and 2 mg/ml leupeptin
vations suggest that the cytoskeleton or its associated (CSBT) (11). After the incubation, cells were centrifuged
proteins may be involved in the assembly and budding of for 5 min at 800 g; the supernatants were collected and
retroviruses. Fractionation studies showed that Rauscher clarified for 5 min at 1500 g (soluble fraction). The Triton
murine leukemia virus Gag associated with the cytoskel- X-100-insoluble pellets were washed twice in CSB. Both
eton (4). Electron microscopy studies showed mouse fractions were solubilized in 51 RIPA buffer and clarified
mammary tumor virus (MMTV) and Rauscher sarcoma at 10,000 g before analysis by immunoprecipitation using
virus budding from cells via surface protrusions con- a pooled antiserum from male HIV-infected patients (Fig.
taining microfilaments (5). Actin has also been detected 1). The purity of the fractions was assessed by determi-
in MMTV- and HIV-1-purified virions (5, 6) and the cy- nation of 5* nucleotidase (a plasma membrane marker
toskeleton has been implicated in HIV-1 transmission protein) and lactate dehydrogenase (a cytosolic marker
from cell to cell (7). Recently, it was reported that treat- protein) (10). Lactate dehydrogenase and 5* nucleotidase
ment of HIV-1-infected lymphoblastoid and monocytoid activities in the soluble fractions were 100 and 80–90%
cells with cytochalasin D, a microfilament destabilizing of the total, respectively. The results from Fig. 1 show that
agent, led to a decrease in virus production (8), as pre- 80% of total Gag was present in the detergent insoluble
viously reported for MMTV (9). Furthermore, Niederman fraction (quantification was performed with a radioana-
et al. showed that bacterial synthesized Gag was able lytic imager (Ambis, San Diego, CA) and it represents
to bind to cytoskeletal structures partially purified from two different experiments). Similar results were obtained
lymphoid cells (10). Evidence is presented here indicat- when another non-ionic detergent, octylglucoside, was
ing that F-actin is the component of the cytoskeleton that employed, suggesting that cytoskeleton–Gag associa-
interacts with the HIV-1 Gag unprocessed polyprotein. tion cannot be due to interaction with Triton X-100-insolu-
To characterize the cellular distribution of Gag, CEM ble lipids (data not shown). The majority of capsid (CA)
cells (a lymphoblastoid cell line) were infected with HIV- and matrix (MA), two of the Gag processing products,
1NL4-3 (m.o.i.: 0.001 infectious units/cell) and at 72 h.p.i. were detected in the detergent-soluble fraction, consis-
cultures were pulse-labeled for 2 hr with Trans-35S-Label tent with an earlier report (12). These results demon-
strated that the unprocessed Gag polyprotein in infected
lymphoid cells associates with the cytoskeleton.1 To whom correspondence and reprint requests should be addressed.
Fax: (310) 206-4764. E-mail: orey@pediatrics.medsch.ucla.edu. Having demonstrated the association of Gag with the
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FIG. 3. Effect of taxol and nocodazole on Gag distribution. COS-7
cells were infected with a recombinant vaccinia virus expressing T7
polymerase (vTF7-3) or HIV-1 Gag (vDK1) and at 13 h.p.i. taxol (lanes
5 and 6) or nocodazole (lanes 7 and 8) was added to the cultures. Three
hours later, soluble and insoluble fractions were obtained, separated by
SDS–PAGE, transferred to nitrocellulose, and membranes decorated
FIG. 1. Gag distribution in HIV-1-infected human T-cells. CEM cells
using a murine monoclonal antibody against MA (A) or a murine mono-
were infected with HIV-1NL4-3 and at 72 h.p.i. cultures were pulse-la- clonal antibody against tubulin (B) and alkaline phosphatase-conju-
beled for 2 hr with Trans-35S-Label. Soluble and insoluble detergent
gated goat anti-mouse immunoglobulins as secondary antibodies. S
fractions were obtained, immunoprecipitated with a pooled antiserum
and I, soluble and insoluble fractions, respectively. Lanes 1 and 2, vTF7-
from male HIV-infected patients, and resolved in a SDS–PAGE. S and
3-infected cells; lanes 3–8, vDK1-infected cells. T, taxol; N, nocodazole.
I, soluble and insoluble fractions, respectively. Lanes 1 and 2, mock-
infected cells; lanes 3 and 4, HIV-infected cells.
amount of Gag was present in the detergent soluble
fraction (Fig. 2, lane 3). Similar results were obtainedcytoskeleton, experiments were performed to determine:
when another adherent cell line, CV-1, was employed(a) if this interaction could be detected when Gag was
(data not shown). Partial cleavage products of Gag wereexpressed alone and (b) if microtubules were involved
also detected, lane 4, in agreement with previous reportsin this interaction.
(14, 15). At the time these fractions were obtained, noCOS-7 cells were infected with a recombinant vaccinia
aggregates of Gag protein were visualized by indirectvirus, vDK1 (AIDS Research and Reference Reagent Pro-
immunofluorescence (data not shown).gram, Division of AIDS, NIAID, NIH), which expresses
These results indicated that the majority of the unpro-HIV-1 Gag (m.o.i.: 3 PFU/cell). After 16 hr, soluble and
cessed Gag polyprotein, expressed using a recombinantinsoluble fractions were obtained as described above.
vaccinia virus in nonlymphoid cells, could be detectedProteins in each fraction were separated by SDS–10%
in the detergent-insoluble fraction in the same fashionPAGE and transferred to nitrocellulose membranes as
observed in HIV-1-infected lymphoid cells. In determiningpreviously described (13). Membranes were decorated
if microtubules were the cytoskeletal component inter-using a murine monoclonal antibody against MA (clone
acting with Gag, taxol and nocodazole were used to af-5.8.42, Cellular Products, Inc., Buffalo, NY) and alkaline
fect the cellular distribution of tubulin. Normally, tubulinphosphatase-conjugated goat anti-mouse immunoglobu-
is found in cells in equal quantities as a free heterodimerlins as secondary antibodies (13). The majority of the
and in the form of polymerized microtubules (1). Nocoda-unprocessed Gag polyprotein was found in the deter-
zole binds to tubulin monomers, inhibiting the formationgent-insoluble fraction (Fig. 2, lane 4), whereas a small
of microtubules. Conversely, taxol binds to and stabilizes
microtubules (1). COS-7 cells were infected with vDK1
(m.o.i.: 3 PFU/cell) and after 13 hr, nocodazole (100 ng/
ml) or taxol (20 mM) was added to the cultures. Three
hours later, detergent-soluble and -insoluble fractions
were obtained and analyzed by Western blot as de-
scribed above. As seen in Fig. 3B, equal amounts of
tubulin were found in the detergent-soluble (lane 1) and
-insoluble fractions (lane 2) in cells infected with a recom-
binant vaccinia virus encoding T7 polymerase (vTF7-3),FIG. 2. Gag distribution in COS-7 cells. COS-7 cells were infected
which was used as a control (16). Infection with vDK1with a recombinant vaccinia virus expressing T7 polymerase (vTF7-3)
or HIV-1 Gag (vDK1) and at 16 h.p.i. soluble and insoluble fractions did not alter the distribution of tubulin, which was again
were obtained. Proteins were separated by SDS–PAGE, transferred to found in equal amounts in detergent-soluble and -insolu-
nitrocellulose, and membranes decorated using a murine monoclonal ble fractions (lanes 3 and 4). However, the addition of
antibody against MA and alkaline phosphatase-conjugated goat anti-
taxol to the infected cultures caused a shift in tubulinmouse immunoglobulins as secondary antibodies. S and I, soluble and
from a detergent-soluble (lane 5) to -insoluble fractioninsoluble fractions, respectively. Lanes 1 and 2, vTF7-3-infected cells;
lanes 3 and 4, vDK1-infected cells. (lane 6) without affecting Gag distribution (Fig. 3A, lanes
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5 and 6). Furthermore, the treatment of the infected cul- mM Tris–HCl, pH 7.4, 1 mM ATP, and 66 mg/ml phalloidin
for 16 hr at 47 (17). A cDNA fragment from pNL4-3 (18)tures with nocodazole caused a shift in tubulin from de-
tergent-insoluble (Fig. 3B, lane 8) to -soluble (lane 7). (nucleotides 712 to 2499) encoding the complete Gag
open reading frame, was blunt-ended with Klenow poly-Despite these effects on tubulin distribution, the majority
of Gag remained in the detergent-insoluble fraction (Fig. merase and subcloned into the SmaI site in pGem3Z
(Promega Corp., Madison, WI) under the control of the3A, lanes 7 and 8), suggesting that this viral protein inter-
acts with some component of the cytoskeleton other than T7 polymerase promoter. RNA transcribed from this vec-
tor was employed to direct Gag synthesis in a rabbitmicrotubules.
Another component of the cytoskeleton, the intermedi- reticulocyte lysate as directed by the manufacturer (Pro-
mega Corp.) in the presence of L-[35S]methionine (ICNate filament network (IF), could be the structure involved
in the association of Gag. This possibility was studied Biomedicals, Inc.). The identity of the in vitro synthesized
Gag was confirmed by immunoprecipitation and SDS–by immunofluorescence of vDK1-infected cells costained
for Gag and vimentin, a protein present in IF (1). The PAGE (data not shown). A fraction of the in vitro trans-
lated Gag was incubated with the in vitro polymerizedresults showed different distribution patterns for these
proteins, making it unlikely that Gag interacts with IF actin (10 mM final concentration) in a buffer containing
75 mM NaCl, 3 mM MgCl2 , 10 mM Tris–HCl, pH 7.4, 3(data not shown). We therefore examined the possibility
that microfilaments (1) are involved in the cytoskeleton mM ATP (ABB) for 2 hr at 47 in a final volume of 150 ml
(17). Samples were then centrifuged in a Beckman air-interaction with Gag. Microfilaments are formed by poly-
merization of globular actin into filaments (F-actin), a pro- fuge for 20 min at 100,000 g. The supernatant was re-
moved and the pellet resuspended in an equivalent vol-cess that can be disrupted by cytochalasin B (CB). By
using CB we expected to observe a modification in the ume of ABB. The supernatant and pellet were solubilized
in 41 SDS sample buffer and equal volumes were ana-intracellular distribution of Gag. CV-1 cells were infected
with vDK1 (m.o.i.: 3 PFU/cell) and 2 h.p.i. CB (2.5 mM) lyzed by SDS–10% PAGE, fluorography, and quantifica-
tion with a radioanalytic imager (Ambis). In Fig. 5A, thewas added to the cultures. After 3 hr of drug treatment,
cells were fixed for 10 min in 10% buffered Formalin majority of the unprocessed Gag polyprotein (90% of the
total) is present in the supernatant when F-actin is notphosphate, washed twice with PBS, and incubated for
10 min at 0207 in 100% acetone. Indirect immunofluores- included in the in vitro binding assay (lane 1). With the
addition of F-actin an average of 70% of Gag was presentcence was performed as previously described (13). Gag
was detected using the a MA MAb, clone 5.8.42, as a in the pelleted fraction (lane 4). These quantitative results
represent the average of seven different experiments.primary antibody and fluorescein-conjugated goat anti-
mouse immunoglobulins as secondary antibodies. For Very similar results were obtained when the binding
assay was performed under more stringent conditionsactin detection, specimens were costained with rhoda-
mine-conjugated phalloidin (Molecular Probes, Inc., Eu- (200 mM NaCl) (data not shown). The interaction be-
tween Gag and F-actin could be mediated by a protein(s)gene, OR). Figures 4A and 4B show the distribution of
Gag and actin, respectively, in vDK1-infected cells. Colo- present in the rabbit reticulocyte lysate. To address this
possibility, in vitro translated Gag was resolved in ancalization of Gag and actin was not wholly apparent, due
to the diffuse signal of Gag (Fig. 4A), although discrete SDS–PAGE and the band representing Gag was electro-
eluted from the gel. This protein was assayed with F-filaments were seen in some cells. Nevertheless, when
the same cells were treated with CB (Figs. 4C and 4D) actin as described above. In Fig. 5B, no detectable Gag
was present in the pelleted fraction in the absence of F-redistribution of Gag and actin was observed. Further-
more, it is apparent that in some areas Gag and actin actin (lane 2). With the addition of F-actin an average of
35% of Gag (average of three different experiments) waswere colocalized (arrows). These data suggest that Gag
interacts with F-actin in microfilaments. At the time points present in the pelleted fraction (lane 4), these results
were obtained even under stringent conditions (200 mMstudied, vaccinia virus infection did not affect microfila-
ments (Fig. 4B). No bleedover of signal from fluorescein NaCl) (data not shown). The amount of Gag present in
the pellet was less than that which bound to F-actinand rhodamine stains between filter settings was de-
tected (data not shown). in assays using unpurified Gag. The decreased binding
could be due to the presence of residual SDS bound toIt is possible that the disruption of the microfilaments
by CB caused a redistribution of Gag due to interactions the electroeluted protein or to the absence of a factor(s)
present in the rabbit reticulocyte lysate. To address thisof this viral protein with another protein(s) bound to F-
actin. To address this point, an in vitro actin-binding question, electroeluted Gag was incubated with F-actin
and different amounts of rabbit reticulocyte lysate. Addi-assay was utilized to determine if this redistribution could
be more specifically correlated with Gag–F-actin interac- tion of reticulocyte lysate did not increase the amount of
binding (data not shown).tion. Rabbit skeletal muscle actin (90% pure) (Sigma
Chem. Co., St. Louis, MO) (4 mg/ml) was polymerized in Authors of previous reports have proposed that cy-
toskeleton-associated proteins or the cytoskeleton itselfvitro in a buffer containing 50 mM KCl, 1 mM MgCl2 , 10
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FIG. 4. Effect of cytochalasin B on Gag distribution. CV-1 cells were infected with vDK1 and 2 h.p.i. cytochalasin B (C, D) was added to the
cultures. After 3 hr of drug treatment, cells were fixed and indirect immunofluorescence was performed as previously described (13). Gag was
detected using a murine monoclonal antibody against MA as primary antibody and fluorescein-conjugated goat anti-mouse immunoglobulins as
secondary antibodies (A, C). For actin detection, specimens were costained with rhodamine-conjugated phalloidin (B, D).
may be involved in the assembly and budding of retrovi- component interacting with Gag. Moreover, it has been
previously reported that the treatment of HIV-infectedruses, including HIV-1 (5 –10). The in vivo and in vitro
experiments presented here indicate that the unpro- cells with cytochalasin D partially inhibited virus release
from the infected cells (8). Nevertheless, our results docessed Gag polyprotein interacts with a cytoskeletal ele-
ment other than microtubules or intermediate filaments. not eliminate the possibility of interaction between Gag
and G-actin. The interaction between Gag and F-actinThe immunofluorescence and in vitro binding assay re-
sults point to F-actin in microfilaments as the cytoskeletal seems to occur in the absence of other proteins. How-
ever, we have not ruled out the possibility that other
viral or cellular polypeptides may also play a role in this
interaction. Binding of Gag to F-actin may be involved in
the assembly or budding of HIV-1 in a fashion similar to
that described for other systems (5, 19). Experiments to
address this question and to map the domain of Gag
involved in actin binding are under way.
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